MedTrace Logo

CTRP3 and Progranulin in Patients With Coronary Artery Disease

NCT01869816 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 362

Last updated 2020-09-02

No results posted yet for this study

Summary

Visceral obesity is the one of the major causes of cardiovascular morbidity and mortality in industrialized countries. Adipose tissue secretes various kinds of bioactive molecules termed adipokines which contribute to the development of obesity-related disorders including cardiovascular disease (CVD). Progranulin and CTRP3 are recently discovered novel adipokines. Therefore, the investigators tried to compare circulating CTRP-3 and progranulin levels in patients with CAD and investigated whether CTRP-3 or progranulin is significantly associated with CAD prevalence after adjustment for well-known CAD risk factors.

Conditions

Sponsors & Collaborators

  • Korea University

    lead OTHER

Principal Investigators

  • Kyung Mook Choi, M.D. · Korea University

Eligibility

Min Age
20 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-03-01
Primary Completion
2012-12-31
Completion
2012-12-31

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01869816 on ClinicalTrials.gov